These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37332102)

  • 1. Dnajb11-Kidney Disease Develops from Reduced Polycystin-1 Dosage but not Unfolded Protein Response in Mice.
    Ghosh Roy S; Li Z; Guo Z; Long KT; Rehrl S; Tian X; Dong K; Besse W
    J Am Soc Nephrol; 2023 Sep; 34(9):1521-1534. PubMed ID: 37332102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease.
    Cornec-Le Gall E; Olson RJ; Besse W; Heyer CM; Gainullin VG; Smith JM; Audrézet MP; Hopp K; Porath B; Shi B; Baheti S; Senum SR; Arroyo J; Madsen CD; Férec C; Joly D; Jouret F; Fikri-Benbrahim O; Charasse C; Coulibaly JM; Yu AS; Khalili K; Pei Y; Somlo S; Le Meur Y; Torres VE; ; ; ; Harris PC
    Am J Hum Genet; 2018 May; 102(5):832-844. PubMed ID: 29706351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis.
    Lemoine H; Raud L; Foulquier F; Sayer JA; Lambert B; Olinger E; Lefèvre S; Knebelmann B; Harris PC; Trouvé P; Desprès A; Duneau G; Matignon M; Poyet A; Jourde-Chiche N; Guerrot D; Lemoine S; Seret G; Barroso-Gil M; Bingham C; Gilbert R; ; ; Le Meur Y; Audrézet MP; Cornec-Le Gall E
    Am J Hum Genet; 2022 Aug; 109(8):1484-1499. PubMed ID: 35896117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bi-allelic pathogenic variations in DNAJB11 cause Ivemark II syndrome, a renal-hepatic-pancreatic dysplasia.
    Jordan P; Arrondel C; Bessières B; Tessier A; Attié-Bitach T; Guterman S; Morinière V; Antignac C; Saunier S; Gubler MC; Heidet L
    Kidney Int; 2021 Feb; 99(2):405-409. PubMed ID: 33129895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystin-1: a master regulator of intersecting cystic pathways.
    Fedeles SV; Gallagher AR; Somlo S
    Trends Mol Med; 2014 May; 20(5):251-60. PubMed ID: 24491980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XBP1 Activation Reduces Severity of Polycystic Kidney Disease due to a Nontruncating Polycystin-1 Mutation in Mice.
    Krappitz M; Bhardwaj R; Dong K; Staudner T; Yilmaz DE; Pioppini C; Westergerling P; Ruemmele D; Hollmann T; Nguyen TA; Cai Y; Gallagher AR; Somlo S; Fedeles S
    J Am Soc Nephrol; 2023 Jan; 34(1):110-121. PubMed ID: 36270750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNAJB11 Mutation in ADPKD Patients: Clinical Characteristics in a Monocentric Cohort.
    Aiello V; Ciurli F; Conti A; Cristalli CP; Lerario S; Montanari F; Sciascia N; Vischini G; Fabbrizio B; Di Costanzo R; Olivucci G; Pietra A; Lopez A; Zambianchi L; La Manna G; Capelli I
    Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38275584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pkd2 Deficiency in Embryonic Aqp2 + Progenitor Cells Is Sufficient to Cause Severe Polycystic Kidney Disease.
    Tsilosani A; Gao C; Chen E; Lightle AR; Shehzad S; Sharma M; Tran PV; Bates CM; Wallace DP; Zhang W
    J Am Soc Nephrol; 2024 Apr; 35(4):398-409. PubMed ID: 38254271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling.
    Xu C; Rossetti S; Jiang L; Harris PC; Brown-Glaberman U; Wandinger-Ness A; Bacallao R; Alper SL
    Am J Physiol Renal Physiol; 2007 Mar; 292(3):F930-45. PubMed ID: 17090781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical ADPKD Due to a
    Kachmar J; El-Haffaf Z; Bollée G
    Can J Kidney Health Dis; 2023; 10():20543581231203054. PubMed ID: 37867501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-terminal tail of polycystin-1 suppresses cystic disease in a mitochondrial enzyme-dependent fashion.
    Onuchic L; Padovano V; Schena G; Rajendran V; Dong K; Shi X; Pandya R; Rai V; Gresko NP; Ahmed O; Lam TT; Wang W; Shen H; Somlo S; Caplan MJ
    Nat Commun; 2023 Mar; 14(1):1790. PubMed ID: 36997516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilia and polycystic kidney disease.
    Ma M
    Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sec63 and Xbp1 regulate IRE1α activity and polycystic disease severity.
    Fedeles SV; So JS; Shrikhande A; Lee SH; Gallagher AR; Barkauskas CE; Somlo S; Lee AH
    J Clin Invest; 2015 May; 125(5):1955-67. PubMed ID: 25844898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain.
    Kurbegovic A; Trudel M
    Hum Mol Genet; 2013 Jun; 22(12):2361-75. PubMed ID: 23439951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage fragments of the C-terminal tail of polycystin-1 are regulated by oxidative stress and induce mitochondrial dysfunction.
    Pellegrini H; Sharpe EH; Liu G; Nishiuchi E; Doerr N; Kipp KR; Chin T; Schimmel MF; Weimbs T
    J Biol Chem; 2023 Sep; 299(9):105158. PubMed ID: 37579949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystin-1 regulates STAT activity by a dual mechanism.
    Talbot JJ; Shillingford JM; Vasanth S; Doerr N; Mukherjee S; Kinter MT; Watnick T; Weimbs T
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7985-90. PubMed ID: 21518865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute kidney injury induces hallmarks of polycystic kidney disease.
    Kurbegovic A; Trudel M
    Am J Physiol Renal Physiol; 2016 Oct; 311(4):F740-F751. PubMed ID: 27488998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
    Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
    J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca
    Yanda MK; Liu Q; Cebotaru V; Guggino WB; Cebotaru L
    J Biol Chem; 2017 Oct; 292(43):17897-17908. PubMed ID: 28887310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of integrin-β1 prevents the development of polycystic kidney disease after the loss of polycystin-1.
    Lee K; Boctor S; Barisoni LM; Gusella GL
    J Am Soc Nephrol; 2015 Apr; 26(4):888-95. PubMed ID: 25145933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.